Summary
Elevance Health, Inc. (formerly WellPoint, Inc.) filed an 8-K on February 8, 2012, primarily to announce the departure of Brian A. Sassi, Executive Vice President, Marketing and President & CEO, Consumer Business Unit. Mr. Sassi was terminated without cause and will remain with the company until early March 2012 to assist with the transition of his duties. This management change, while notable, appears to be an isolated event and the company has provided a statement regarding its implications. In addition to the executive departure, WellPoint also reaffirmed its full-year 2012 earnings per share (EPS) guidance of at least $7.60. This guidance is expected to be communicated to securities analysts and investors during meetings scheduled from February 8 to February 23, 2012. The company also included a standard safe harbor statement for forward-looking information, highlighting various risks and uncertainties that could affect future performance, including those related to healthcare reform, market trends, and regulatory environments.
Key Highlights
- 1Termination of Brian A. Sassi, EVP, Marketing & President & CEO, Consumer Business Unit, without cause.
- 2Mr. Sassi to remain employed through early March 2012 to facilitate a smooth transition.
- 3Reaffirmation of full-year 2012 EPS guidance of at least $7.60 per share.
- 4Guidance to be discussed with securities analysts and investors between February 8 and February 23, 2012.
- 5Inclusion of a standard safe harbor statement for forward-looking information.
- 6Disclosure of various risks and uncertainties that could impact future financial results.